Breaking News Instant updates and real-time market news.

SMMT

Summit Therapeutics

$8.65

-0.414 (-4.57%)

14:54
10/04/16
10/04
14:54
10/04/16
14:54

Summit Therapeutics price target raised to $42 from $24 at JMP Securities

  • 04

    Oct

SMMT Summit Therapeutics
$8.65

-0.414 (-4.57%)

06/21/16
JANY
06/21/16
INITIATION
Target $15
JANY
Buy
Summit Therapeutics initiated with a Buy at Janney Capital
Janney Capital analyst Debjit Chattopadhyay started coverage of Summit Therapeutics with a Buy rating and $15 fair value estimate as he believes the company's pre-clinical data has been compelling and that two upcoming data reads should clarify its outlook and provide a catalyst for the stock.
09/16/16
HCWC
09/16/16
INITIATION
Target $26
HCWC
Buy
Summit Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther initiated Summit Therapeutics with a Buy and a $26 price target saying Ezutromid in DMD can potentially generate $1.2B in global sales in FY26.
10/04/16
PIPR
10/04/16
NO CHANGE
Target $68
PIPR
Overweight
Piper Jaffray ups Sarepta target to $68 on Summit deal
Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics (SRPT) to $68 from $64 after the company licensed Summit Therapeutics' (SMMT) ezutromid to treat Duchenne Muscular Dystrophy in Europe, Turkey and the Commonwealth of Independent States. The deal is a smart way for Sarepta to capitalize on its lead in DMD with the recent FDA approval of Exondys51, Tenthoff tells investors in an intraday research note. His new price target of $68 reflects the value of ezutromid. Tenthoff reiterates an Overweight rating on Sarepta. The stock is up 1% to $61.61 in late morning trading. Summit is up 94%, or $8.17, to $16.82.
10/04/16
NEED
10/04/16
NO CHANGE
Target $30
NEED
Buy
Summit Therapeutics price target raised to $30 from $22 at Needham
Sarepta Therapeutics (SRPT) and Summit Therapeutics (SMMT) announced this morning that they have entered into an exclusive license and collaboration agreement granting Sarepta rights in Europe, as well as in Turkey and the Commonwealth of Independent States, to Summit's utrophin modulator pipeline, including its lead clinical candidate, ezutromid, for the treatment of Duchenne muscular dystrophy.

TODAY'S FREE FLY STORIES

ANY

Sphere 3D

$0.17

-0.0854 (-33.31%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Conference/Events
Sphere 3D to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

FRTA

Forterra

$7.73

0.18 (2.38%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Hot Stocks
Forterra to sell U.S. concrete, steel pressure pipe assets to Thompson Pipe »

Forterra announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.28

0.48 (6.15%)

, SIRI

SiriusXM

$5.35

0.11 (2.10%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Recommendations
Pandora, SiriusXM analyst commentary  »

Pandora added to Alpha…

P

Pandora

$8.28

0.48 (6.15%)

SIRI

SiriusXM

$5.35

0.11 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TROV

Trovagene

$1.14

-0.16 (-12.31%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Trovagene announces expansion of key claims for NPM1 patent portfolio »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$31.55

-0.18 (-0.57%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Conference/Events
National Bank to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 18

    Sep

CKPT

Checkpoint Therapeutics

$10.00

0.25 (2.56%)

, FBIO

Fortress Biotech

$4.87

0.05 (1.04%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Checkpoint Therapeutics commences trading on Nasdaq Capital Market »

Checkpoint Therapeutics…

CKPT

Checkpoint Therapeutics

$10.00

0.25 (2.56%)

FBIO

Fortress Biotech

$4.87

0.05 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SPA

Sparton

$18.34

0.03 (0.16%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Sparton confirms discussions with Ultra Electronics »

Sparton Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SON

Sonoco Products

$51.02

0.08 (0.16%)

08:01
06/26/17
06/26
08:01
06/26/17
08:01
Hot Stocks
Sonoco Products to acquire Clear Lam Packaging for approx. $170M in cash »

Sonoco announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 19

    Oct

LC

LendingClub

$5.67

-0.03 (-0.53%)

08:01
06/26/17
06/26
08:01
06/26/17
08:01
Hot Stocks
LendingClub executives under investigation »

Shareholder and consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSDV

pSivida

$1.91

0.09 (4.95%)

08:01
06/26/17
06/26
08:01
06/26/17
08:01
Conference/Events
pSivida to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 13

    Jul

  • 14

    Jul

  • 26

    Sep

LPCN

Lipocine

$4.21

-0.11 (-2.55%)

08:00
06/26/17
06/26
08:00
06/26/17
08:00
Hot Stocks
Lipocine announces submission of SPA on LPCN 1107 »

Lipocine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BAH

Booz Allen

$32.22

-0.67 (-2.04%)

08:00
06/26/17
06/26
08:00
06/26/17
08:00
Recommendations
Booz Allen analyst commentary  »

Booz Allen selloff an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 07

    Aug

SPGI

S&P Global

$146.70

1.32 (0.91%)

08:00
06/26/17
06/26
08:00
06/26/17
08:00
Options
S&P Global call buyer realizes 15% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUTR

Cutera

$24.50

-0.2 (-0.81%)

07:59
06/26/17
06/26
07:59
06/26/17
07:59
Initiation
Cutera initiated  »

Cutera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

  • 28

    Sep

PM

Philip Morris

$119.56

-0.15 (-0.13%)

07:59
06/26/17
06/26
07:59
06/26/17
07:59
Hot Stocks
Philip Morris to invest additional EUR500M in heated tobacco facility in Italy »

Philip Morris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$47.70

1.37 (2.96%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

07:58
06/26/17
06/26
07:58
06/26/17
07:58
Downgrade
GrubHub, Amazon.com rating change  »

GrubHub downgraded to…

GRUB

GrubHub

$47.70

1.37 (2.96%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AAPL

Apple

$146.28

0.65 (0.45%)

07:57
06/26/17
06/26
07:57
06/26/17
07:57
Periodicals
Apple hires Stanford researcher for digital health, Digital Commerce 360 says »

Apple has hired Sumbul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NBHC

National Bank

$31.55

-0.18 (-0.57%)

07:57
06/26/17
06/26
07:57
06/26/17
07:57
Hot Stocks
National Bank acquires Peoples in $143M transaction »

National Bank and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

07:56
06/26/17
06/26
07:56
06/26/17
07:56
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOXX

VOXX

$7.85

0.25 (3.29%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on VOXX »

VOXX trading halted, news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOT

Neothetics

$2.32

0.0501 (2.21%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on Neothetics »

Neothetics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHM

Autohome

$45.47

-0.15 (-0.33%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Conference/Events
Autohome to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NSU

Nevsun Resources

$2.27

-0.02 (-0.87%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Hot Stocks
Nevsun Resources names Ian Pearce as Board Chair, effective June 30 »

Nevsun Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$32.02

0.9 (2.89%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Hot Stocks
MPLX sees FY17 net income $550M-$700M, adjusted EBITDA $1.7B-$1.85B »

Sees FY net cash provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

REGN

Regeneron

$517.33

-9.2 (-1.75%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Downgrade
Regeneron rating change  »

Regeneron downgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.